Widely-Used Cancer Drug Curbs Vision Loss in Eye Cancer Patients

Upload: November 25, 2015According to a study authored by Dr. Paul Finger, injections of a widely-used cancer drug curbs vision loss due to radiation treatment of eye cancer.

“This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy. Avastin reduces abnormal blood vessel growth, stops leakage in the eye and the patients wind up seeing better. This is a first.”

According to a Reuters report, Finger and co-author Dr. Kimberly Chin found that eye injections of Avastin in patients undergoing radiation retinopathy led to improvement in vision within three months:

The drug improved or stabilized vision in all patients by reducing abnormal blood vessel growth, leakage in the eye and swelling – the major causes of irreversible loss of vision in patients with radiation retinopathy, they note.”

“Before these Avastin findings, there was no effective treatment for macular radiation retinopathy,” Dr. Finger said.

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
N.N.

Read More

REQUEST AN APPOINTMENT

  • This field is for validation purposes and should be left unchanged.

CONNECT AND SHARE